SIRT6 and pancreatic neoplasm: Furthermore, JYQ-42 inhibited the activity of SIRT6 and had a killing effect on pancreatic cancer cells [36], and even a SIRT6 allosteric activator (MDL-800) was reported to have anticancer effects [37].